High fat diet and food restriction differentially modify the behavioral effects of quinpirole and raclopride in rats

European Journal of Pharmacology

Volumn 610, Issue 1-3, 2009, Pages 55-60

  Baladi, Michelle G ^a   France, Charles P ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Dopamine receptor; Food restriction; High fat diet; Quinpirole; Raclopride; Yawning

Indexed keywords

QUINPIROLE; RACLOPRIDE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; BODY TEMPERATURE; CATALEPSY; CONTROLLED STUDY; DIET RESTRICTION; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG ABUSE; DRUG EFFECT; DRUG SENSITIVITY; HYPOTHERMIA; LIPID DIET; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; YAWNING;

ANIMALS; BEHAVIOR, ANIMAL; BODY WEIGHT; CALORIC RESTRICTION; CATALEPSY; DIET; DIETARY FATS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; QUINPIROLE; RACLOPRIDE; RATS; RATS, SPRAGUE-DAWLEY; SENSITIVITY AND SPECIFICITY; YAWNING;

EID: 65049090983     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.03.048     Document Type: Article

References (46)

1. Alcock S.J., Hemsley K.M., and Crocker A.D. Atropine acts in the ventral striatum to reduce raclopride-induced catalepsy. Eur. J. Pharmacol. 424 (2001) 179-187
2. Boulay D., Depoortere R., Perrault G., Borreill E., and Sanger D.J. Dopamine D2 receptor knock-out mice are insensitive to the hypolocomotor and hypothermic effects of dopamine D2/D3 receptor agonists. Neuropharmacology 38 (1999) 1389-1396
3. Carroll M.E., France C.P., and Meisch R.A. Intravenous self-administration of etonitazene, cocaine, and phencyclidine in rats during food deprivation and satiation. J. Pharmacol. Exp. Ther. 217 (1981) 241-247
4. Carr K.D. Augmentation of drug reward by chronic food restriction: behavioral evidence and underlying mechanisms. Physiol. Behav. 76 (2002) 353-364
5. Carr K.D. Chronic food restriction: enhancing effects on drug reward and striatal cell signaling. Physiol. Behav. 91 (2006) 459-472
6. Carr K.D., Tsimberg Y., Berman Y., and Yamamoto N. Evidence of increased dopamine receptor signaling in food-restricted rats. Neuroscience 119 (2003) 1157-1167
7. Chaperon F., Tricklebank M., Unger L., and Neijt H. Evidence for regulation of body temperature in rats by dopamine D2 receptor and possible influence of D1 but not D3 and D4 receptors. Neuropharmacology 44 (2003) 1047-1053
8. Collins G.T., Calinski D.M., Newman A.H., Grundt P., and Woods J.H. Food restriction alters pramipexole-induced yawning, hypothermia, and locomotor activity in rats: evidence for sensitization of dopamine D2 receptor-mediated effects. J. Pharmacol. Exp. Ther. 325 (2008) 691-697
9. Collins G.T., Newman A.H., Grundt P., Rice K.C., Husbands S.M., Chauvignac C., Chen J., Wang S., and Woods J.H. Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonists. Psychopharmacology 193 (2007) 159-170
10. Collins G.T., Witkin J.M., Newman A.H., Svensson K.A., Grundt P., Cao J., and Woods J.H. Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior. J. Pharmacol. Exp. Ther. 314 (2005) 310-319
11. Davis J.F., Tracy A.L., Schurdak J.D., Tschöp M.H., Lipton J.W., Clegg D.J., and Benoit S.C. Exposure to elevated levels of dietary fat attenuates psychostimulant reward and mesolimbic dopamine turnover in the rat. Behav. Neurosci. 122 (2008) 1257-1263
12. Di Chiara G., and Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U. S. A. 85 (1988) 5274-5280
13. Figlewicz D.P., Patterson T.A., Johnson L.B., Zavosh A., Israel P.A., and Szot P. Dopamine transporter mRNA is increased in the CNS of Zucker fatty (fa/fa) rats. Brain Res. Bull. 46 (1998) 199-202
14. Figlewicz D.P., Szot P., Chavez M., Woods S.C., and Veith R.C. Intraventricular insulin increases dopamine transporter mRNA in rat VTA/substantia nigra. Brain Res. 644 (1994) 331-334
15. Galici R., Galli A., Jones D.J., Sanchez T.A., Saunders C., Frazer A., Gould G.G., Lin R.Z., and France C.P. Selective decreases in amphetamine self-administration and regulation of dopamine transporter function in diabetic rats. Neuroendocrinology 77 (2003) 132-140
16. Gratton A., and Wise R.A. Drug- and behavior-associated changes in dopamine-related electrochemical signals during intravenous cocaine self-administration in rats. J. Neurosci. 14 (1994) 4130-4146
17. Hajnal A., Margas W.M., and Covasa M. Altered dopamine D2 receptor function and binding in obese OLETF rat. Brain Res. Bull. 75 (2008) 70-76
18. Holderness C.C., Brooks-Gunn J., and Warren M.P. Co-morbidity of eating disorders and substance abuse review of the literature. Int. J. Eat. Disord. 16 (1994) 1-34
19. Huang X.F., Zavitsanou K., Huang X., Yu Y., Wang H., Chen F., Lawrence A.J., and Deng C. Dopamine transporter and D2 receptor binding densities in mice prone or resistant to chronic high fat diet-induced obesity. Behav. Brain Res. 175 (2006) 415-419
20. Kanes S.J., Hitzemann B.A., and Hitzemann R.J. On the relationship between D2 receptor density and neuroleptic-induced catalepsy among eight inbred strains of mice. J. Pharmacol. Exp. Ther. 267 (1993) 538-547
21. Kebabian J.W., Tarazi F.I., Kula N.S., and Baldessarini R.J. Compounds selective for dopamine receptor subtypes. Drugs Discov. Today 2 (1997) 333-340
22. Klemm W.R. Evidence for a cholinergic role in haloperidol-induced catalepsy. Psychopharmacology 87 (1985) 12-15
23. Koek W., Carter L.P., Wu H., Coop A., and France C.P. Discriminative stimulus effects of flumazenil: perceptual masking by baclofen, and lack of substitution with gamma-hydroxybutyrate and its precursors 1,4-butanediol and gamma-butyrolactone. Behav. Pharmacol. 17 (2006) 239-247
24. Krahn D.D. The relationship of eating disorders and substance abuse. J. Subst. Abuse 3 (1991) 239-253
25. Kurashima M., Yamada K., Nagashima M., Shirakawa K., and Furukawa T. Effects of putative dopamine D3 receptor agonists, 7-OH-DPAT, and quinpirole, on yawning, stereotypy, and body temperature in rats. Pharmacol. Biochem. Behav. 52 (1995) 503-508
26. Naef L., Srivastava L., Gratton A., Hendrickson H., Owens S.M., and Walker C.D. Maternal high fat diet during the perinatal period alters mesocorticolimbic dopamine in the adult rat offspring: reduction in the behavioral responses to repeated amphetamine administration. Psychopharmacology 197 (2007) 83-94
27. Nunes J.L., Sharif N.A., Michel A.D., and Whiting R.L. Dopamine D2-receptors mediate hypothermia in mice: ICV and IP effects of agonists and antagonists. Neurochem. Res. 16 (1991) 1167-1174
28. Owens W.A., Sevak R.J., Galici R., Chang X., Javors M.A., Galli A., France C.P., and Daws L.C. Deficits in dopamine clearance and locomotion in hypoinsulinemic rats unmask novel modulation of dopamine transporters by amphetamine. J. Neurochem. 94 (2005) 1402-1410
29. Palmiter R.D. Is dopamine a physiologically relevant mediator of feeding behavior?. Trends Neurosci. 30 (2007) 375-381
30. Patterson T.A., Brot M.D., Zavosh A., Schenk J.O., Szot P., and Figlewicz D.P. Food deprivation decreases mRNA and activity of the rat dopamine transporter. Neuroendocrinology 68 (1998) 11-20
31. Persinger M.A., Stewart L.S., Richards P.M., Harrigan T., O'Connor R.P., and Bureau Y.R. Seizure onset times for rats receiving systemic lithium and pilocarpine: sources of variability. Pharmacol. Biochem. Behav. 71 (2002) 7-17
32. Piran N., and Robinson S.R. Associations between disordered eating behaviors and licit and illicit substance use and abuse in a university sample. Addict. Behav. 31 (2006) 1761-1775
33. Pothos E.N., Creese I., and Hoebel B.G. Restricted eating with weight loss selectively decreases extracellular dopamine in the nucleus accumbens and alters dopamine response to amphetamine, morphine, and food intake. J. Neurosci. 10 (1995) 6640-6650
34. Reavill C., Taylor S.G., Wood M.D., Ashmeade T., Austin N.E., Avenell K.Y., Boyfield I., Branch C.L., Cilia J., Coldwell M.C., Hadley M.S., Hunter A.J., Jeffrey P., Jewitt F., Johnson C.N., Jones D.N., Medhurst A.D., Middlemiss D.N., Nash D.J., Riley G.J., Routledge C., Stemp G., Thewlis K.M., Trail B., Vong A.K., and Hagan J.J. Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist, SB-277011-A. J. Pharmacol. Exp. Ther. 294 (2000) 1154-1165
35. Schultz W., Apicella P., and Ljungberg T. Responses of monkey dopamine neurons to reward and conditioned stimuli during successive steps of learning a delayed response task. J. Neurosci. 13 (1993) 900-913
36. Sevak R.J., Daws L.C., Koek W., Owens W.A., Galli A., and France C.P. Feeding conditions differentially affect the neurochemical and behavioral effects of dopaminergic drugs in male rats. Eur. J. Pharmacol. 592 (2008) 109-115
37. Sevak R.J., France C.P., and Koek W. Neuroleptic-like effects of γ-hydroxybutyrate: interactions with haloperidol and dizocilpine. Eur. J. Pharmacol. 483 (2004) 289-293
38. Sevak R.J., Koek W., Galli A., and France C.P. Insulin replacement restores the behavioral effects of quinpirole and raclopride in streptozotocin-treated rats. J. Pharmacol. Exp. Ther. 32 (2006) 1216-1223
39. South T., and Huang X. High-fat diet exposure increase dopamine D2 receptor and decreases dopamine transporter receptor binding density in the nucleus accumbens and caudate putamen of mice. Neurochem. Res. 35 (2008) 598-605
40. Takahashi R.N., Singer G., and Oei T. Schedule-induced self-injection of d-amphetamine by naïve animals. Pharmacol. Biochem. Behav. 9 (1978) 857-861
41. Tallarida, R.J., 2000. Drug synergism and dose-effect data analysis. Boca Raton: Chapman & Hall/CRC.
42. 3H] spiperone) autoradiograph. Synapse 62 (2008) 50-61
43. Ushijima I., Kawano M., Kaneyuki H., Suetsugi M., Usami K., Hirano H., Mizuki Y., and Yamada M. Dopaminergic and cholinergic interaction in cataleptic response in mice. Pharmacol. Biochem. Behav. 58 (1997) 103-108
44. Wadenberg M.L., Kapur S., Soliman S., Jones C., and Vaccarino F. Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats. Psychopharmacology 150 (2000) 422-429
45. Wang G.J., Volkow N.D., Thanos P.K., and Fowler J.S. Similarity between obesity and drug addiction as assessed by neurofunctional imaging: a concept review. J. Addict. Dis. 23 (2004) 39-53
46. Wise R.A., and Rompre P.P. Brain dopamine and reward. Annu. Rev. Psychol. 40 (1989) 191-225